A Single-arm Single-center Trial of Bridging GPRC5D/CD3 Bispecific Antibody Treatment With BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma
EARLY_PHASE1
This study is a prospective, single-arm, multicenter trial designed to eval...
A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Participants With Relapsed or Refractory Multiple Myeloma
PHASE3
The purpose of this study is to compare the safety and efficacy of QLS32015...
Status
Recruiting
Location
National Clinical Research Center for Blood Diseases